Author

John Cronin

Observed names: J Cronin, J. Cronin

Institution: Apnimed (United States)

Observed institution: Apnimed (United States)

OpenAlex ID: A5135721063

Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy)

2026 · Patrick J Strollo, Ron Farkas, et al. · American Journal of Respiratory and Critical Care Medicine · 17

A79-16 Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea: A Pooled Analysis of the SynAIRgy and LunAIRo Phase 3 Trials

2026 · S R Patel, R Farkas, et al. · American Journal of Respiratory and Critical Care Medicine · 1

A82-04 Aroxybutynin And Atomoxetine (AD109) In Obstructive Sleep Apnea

2026 · S R Patel, R Farkas, et al. · American Journal of Respiratory and Critical Care Medicine

Content validity and clinically meaningful change on patient-reported outcome measures for use in obstructive sleep apnea

2026 · Joseph M. Ojile, Kristina S. Yu, et al. · Sleep Medicine

0589 Concomitant Aroxybutynin and Atomoxetine (AD109) with GLP-1 Agonists: An Analysis of the SynAIRgy and LunAIRo Trials in Obstructive Sleep Apnea

2026 · Patrick Strollo, Huy Pho, et al. · SLEEP

0672 Pharmacokinetics, Efficacy, and Safety of AD109 (Aroxybutynin and Atomoxetine) in Participants with Obstructive Sleep Apnea and Obesity Taking a GLP-1

2026 · Hsuan-Ming Yao, Laura Gell, et al. · SLEEP

0656 Psychometric Validation of the PROMIS Fatigue 8a, PROMIS Sleep Impairment 8a and ESS in Adults with Mild to Severe Obstructive Sleep Apnea

2026 · Kristina Yu, Shauna McManus, et al. · SLEEP

0679 Aroxybutynin and Atomoxetine (AD109) and Patient-Reported Outcomes: A Pooled Analysis of the SynAIRgy and LunAIRo Trials in Obstructive Sleep Apnea

2026 · Patrick Strollo, Douglas Kirsch, et al. · SLEEP

0527 Obstructive Sleep Apnea Patient Journey from First Symptom to Confirmed Diagnosis: A Real-world Analysis of Patients in the United States

2026 · Chris Schmickl, Kristina Yu, et al. · SLEEP

0539 Obstructive Sleep Apnea Management in Practice: Real-World Treatment Patterns Highlight Persistent Gaps in Care

2026 · Chris Schmickl, Kristina Yu, et al. · SLEEP

A30-01 Longitudinal Sensor-based Monitoring of Oxygenation Metrics: An Evaluation of Oxygen Desaturation Index in a Phase 3 Open-label Extension Study

2026 · K Mehta, S R Patel, et al. · American Journal of Respiratory and Critical Care Medicine

Real-world Incremental Economic Burden of Fatigue among Patients with Obstructive Sleep Apnea in the Medicare Fee-for-Service Population

2026 · K.S. Yu, N.F. Watson, et al. · Sleep Medicine

Unmasking Obstructive Sleep Apnea: Estimated Prevalence and Impact in the United States

2026 · I. Sönmez, A. Vo Dupuy, et al. · Sleep Medicine

Demographic and Baseline Disease Characteristics of SynAIRgy: A Phase 3 Trial of Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea

2026 · P.J. Strollo, J. Cronin, et al. · Sleep Medicine

Works count: 14

Citation count: 18

H-index: 1

I10-index: 1